Primary record
4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE, HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-, (3A.ALPHA.,4.BETA.,7.BETA.,7A.ALPHA.)-
- 库存
- 4,823 克
- 纯度
- 99.7 %
- CAS
- 87760-53-0
化合物标识与属性
- CAS
- 87760-53-0
- PubChem CID
- 91273
- SMILES
- C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5
- Canonical SMILES
- O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1
名称与同义词
- Tandospirone
- tandospirona
- tandospironum
- 87760-53-0
- Metanopirone
- Sediel
- metanopirone citrate
- tandospirone citrate
- Sediel (TN)
- Tandospirone (INN)
- [14C]-Tandospirone
- SM-3997 citrate
- Tandospirone (citrate)
- Tandospirone [INN:BAN]
- Tandospirone (Standard)
- AC1L3LQY
- RefChem:187377
- TANDOSPIRONE [MI]
- DTXSID6048836
- TANDOSPIRONE [INN]
- D06OSM
- GTPL55
- CHEMBL274047
- SM-3997
- SCHEMBL49026
- DTXCID3028762
- TANDOSPIRONE [WHO-DD]
- CHEBI:145673
- MFCD00904852
- C21H29N5O2
- orb1678989
- TANDOSPIRONE HYDROCHLORIDE
- Tandospirone, >=98% (HPLC)
- CEIJFEGBUDEYSX-FZDBZEDMSA-N
- UNII-190230I669
- CID 5378
- CID91273
- SM 3997
- ZINC1545034
- Tox21_113318
- 4083AH
- AC-754
- BDBM50099385
- BDBM50368723
- HY-14558R
- MSK158275
- NCGC00182990-01
- AKOS015966978
- CS-1709
- DB12833
- FT28000
- AJ-26873
- AN-15539
- AS-77283
- HY-14558
- CAS-87760-53-0
- J353.759E
- 190230I669
- B1199
- FT-0674806
- NS00068624
- ST24049324
- D08561
- SBI-0654213.0001
- (3aR,4S,7R,7aS)-2-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
- A897877
- Q6151362
- BRD-K65904673-001-01-4
- (1S,2R,6S,7R)-4-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
- 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aalpha,4beta,7beta,7aalpha)-
- B2693-099721
- 112457-95-1
- (1R*,2S*,3R*,4S*)-N-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-2,3-NORBORNANEDICARBOXIMIDE
- (3aR,4S,7R,7aS)-2-{4-[4-(Pyrimidin-2-yl)piperazin-1-yl]butyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione
- (1R*,2S*,3R*,4S*)-N-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-2,3-norbornanedicarboximide citrate salt
- (1R,2S,6R,7S)-4-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-4-azatricyclo(5.2.1.0^(2,6))decane-3,5-dione
- (1R,2S,6R,7S)-4-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-4-azatricyclo[5.2.1.0^{2,6}]decane-3,5-dione
- (1R,2S,6R,7S)-4-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-4-azatricyclo[5.2.1.02,6]decane-3,5-dione
- (1S,2R,6S,7R)-4-(4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl)-4-aza-tricyclo(5.2.1.0*2,6*)decane-3,5-dione
- (1S,2R,6S,7R)-4-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-4-aza-tricyclo[5.2.1.0*2,6*]decane-3,5-dione
- (3a|_,4|_,7|_,7a|_)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione
- (3aalpha,4beta,7beta,7aalpha)-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione
- (3aR,4S,7R,7aS)-rel-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione
- 3a,4,7,7a-hexahydro-2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-4,7-methano-1H-isoindole-1,3(2H)-dione
- 4,7-Methano-1H-Isoindole-1,3(2h)-Dione, Hexahydro-2-(4-(4-(2-Pyrimidinyl)-1-Piperazinyl)Butyl)-, (3a-Alpha,4Beta,7Beta,7a-Alpha)-
- 4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE, HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-, (3A.ALPHA.,4.BETA.,7.BETA.,7A.ALPHA.)-
- 4,7-METHANO-1H-ISOINDOLE-1,3(2H)-DIONE, HEXAHYDRO-2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-, (3AR,4S,7R,7AS)-REL-
- 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3a|A,4|A,7|A,7a|A)-
- 4,7-Methano-1H-isoindole-1,3(2H)-dione, hexahydro-2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-, (3aa,4ss,7ss,7aa)-
- 685-029-2